CA
IDXX icon

CastleArk Alternatives’s Idexx Laboratories IDXX Stock Holding History

CastleArk Alternatives’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-705
Closed -$438K – 138
2021
Q3 		$438K Buy
+705
New +$474K 0.02% 258

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CastleArk Alternatives's IDXX Position: Q4 2021 in Review

CastleArk Alternatives sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 705 shares — an estimated $438K sold.

CastleArk Alternatives first reported a position in IDXX in Q3 2021 and held it in 1 quarter. The position peaked at $438K in Q3 2021. 1,107 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

  • CastleArk Alternatives reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
  • CastleArk Alternatives sold 705 Idexx Laboratories shares in Q4 2021, an estimated $438K.
  • CastleArk Alternatives first reported a position in Idexx Laboratories in Q3 2021 and held it in 1 quarter.
  • CastleArk Alternatives's Idexx Laboratories position peaked at $438K in Q3 2021.
  • 1,107 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.